| ¿µ¹® | basal metabolic rate(BMR) | ÇÑ±Û | ±âÃÊ´ë»çÀ² |
|---|---|---|---|
| ¼³¸í | Ç¥ÁØ ±âÃÊ´ë»ç·®°ú ºñ±³ÇßÀ» ¶§ °³Ã¼ ±âÃÊ´ë»ç·®ÀÌ º¸ÀÌ´Â ÆíÂ÷¸¦ Ç¥½ÃÇÏ´Â Áö¼ö. ±âÃÊ´ë»ç·®Àº »ý¸íÀ» À¯ÁöÇϴµ¥ ÇÊ¿äÇÑ ÃÖ¼ÒÇÑÀÇ ¿¡³ÊÁö ´ë»ç·®À̸ç, ¼º°ú ¿¬·ÉÀÌ µ¿ÀÏÇÑ °Ç°ÀÎÀÇ ±âÃÊ´ë»ç·®Àº üǥ¸éÀû¿¡ ºñ·ÊÇÑ´Ù. À̰ÍÀ» üǥ¸éÀûÀÇ ¹ýÄ¢À̶ó°í Çϸç, 1882³â µ¶ÀÏÀÇ ´ë»ç»ý¸®ÇÐÀÚ M. ºê·ç³Ê¿¡ ÀÇÇØ Á¦Ã¢µÇ¾ú´Ù. üǥ¸éÀûÀº ½ÅÀå°ú üÁß¿¡ ÀÇÇØ »êÃâµÈ´Ù. µû¶ó¼ ¼º-¿¬·É-½ÅÀå-üÁßÀ» ¾Ë¸é Ç¥ÁرâÃÊ·® Y°¡ »êÃâµÇ°í ½ÇÁ¦ÀÇ ±âÃÊ´ë»ç·® X´Â »ê¼Ò¼Òºñ·®°ú ÀÌ»êÈź¼Ò ¹ß»ý·®¿¡¼ »êÃâµÈ´Ù. ±×¸®°í X¿Í YÀÇ Â÷À̸¦ Y·Î ³ª´« °ª(%)À» ±âÃÊ´ë»çÀ²À̶ó°í ÇÑ´Ù. °æÇèÀûÀ¸·Î ¾òÀº BMRÀÇ °£´ÜÇÑ ÃøÁ¤¹ýµµ ÀÖÀ¸¸ç ´ÙÀ½°ú °°Àº ½ÄÀ¸·Î ±¸ÇÑ´Ù. ÀÌ ½Ä¿¡¼ ¸ÆÆøÀ̶õ ÃÖ°íÇ÷¾Ð°ú ÃÖÀúÇ÷¾ÐÀÇ Â÷¸¦ ¸»ÇÑ´Ù. BMR(%)=0.75(1ºÐ ¸Æ¹Ú¼ö + 0.74¡¿¸ÆÆø)£72. BMRÀÌ 10% À̳»À̸é Á¤»ó¹üÀ§, +10% ÀÌ»óÀÌ¸é ±âÃÊ´ë»çÇ×Áø, £10% ÀÌÇÏÀÌ¸é ±âÃÊ´ë»ç ÀúÇ϶ó°í ÇÑ´Ù. ±âÃÊ´ë»ç´Â °øº¹½Ã(½ÄÈÄ 10½Ã°£ °æ°ú)¿¡ ¾ÈÁ¤µÈ »óÅ¿¡¼ ´ÜÀ§ ½Ã°£´ç ÀÌ¿ëµÇ´Â ¿¡³ÊÁöÀÇ ¾ç, Áï, ÇÑ ½Ã°£´ç, ¸ö Ç¥¸éÀÇ 1m2´ç ¶Ç´Â ¸ö¹«°Ô 1kg ´ç Ä®·Î¸®·Î ³ªÅ¸³½´Ù. À̰ÍÀº °³Àο¡ µû¶ó ´Ù¸£¸ç Àå±â°£¿¡´Â °ÅÀÇ º¯È°¡ ¾øÁö¸¸ Áúº´ µîÀ¸·Î ÀÎÇØ º¯µ¿µÈ´Ù. ½ÇÃøÇÑ ±âÃÊ´ë»ç¸¦ Ç¥ÁØÄ¡¿Í ºñ±³ÇÔÀ¸·Î½á Áúº´ÀÇ Áø´Ü µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ´Ù BMR=(½ÇÃøÄ¡-Ç¥ÁØÄ¡)/Ç¥ÁØÄ¡ ¡¿100(%)·Î ³ªÅ¸³½´Ù. |
||
| ¿µ¹® | bone marrow | ÇÑ±Û | °ñ¼ö |
|---|---|---|---|
| ¼³¸í | Ç÷±¸¼¼Æ÷¸¦ »ý¼ºÇÏ´Â Àå¼Ò¸¦ À̸£´Â ¸». ¾î¸°ÀÌ¿¡ À־ ¸ðµç »À¿¡ °ñ¼ö°¡ Á¸ÀçÇÏÁö¸¸ ¾î¸¥ÀÌ µÇ¸é ´ë°³ ±ä»ÀÀÇ ³»ºÎ³ª ³³ÀÛ»ÀÀÇ ³»ºÎ¿¡¸¸ Á¸ÀçÇÑ´Ù. Ç÷±¸¸¦ ¿Õ¼ºÇÏ°Ô »ý¼ºÀ» ÇÏ´Â °ñ¼ö´Â Àû»öÀ» ¶ì°Ô µÇ¹Ç·Î À̰ÍÀ» Àû»ö°ñ¼ö¶ó°í ÇÑ´Ù. Ç÷¾×À» »ý¼ºÇÏÁö ¾Ê´Â °ñ¼öÀÇ °æ¿ì´Â ±×°÷¿¡ Áö¹æÁúÀÇ Ä§ÂøÀÌ ÀÖ¾î¼ È²»öÀ¸·Î º¯»öµÇ¹Ç·Î À̰÷À» Ȳ»ö°ñ¼ö¶ó°í ÇÑ´Ù. ¾î¸¥¿¡ À־ ¸î¸îÀÇ »À¸¦ Á¦¿ÜÇÏ°í °ÅÀÇ ÀüºÎ°¡ Àû»ö°ñ¼ö°¡ Ȳ»ö°ñ¼ö·Î ´ëÄ¡µÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | bone marrow biopsy | ÇÑ±Û | °ñ¼ö»ý°Ë |
|---|---|---|---|
| ¼³¸í | °ñ¼ö¸¦ Áø´ÜÀ̳ª º´¿¡ ÀÇÇÑ º¯È¸¦ ¾Ë±âÀ§Çؼ äÃëÇÏ´Â °Í. |
||
| ¿µ¹® | bone marrow transplantation | ÇÑ±Û | °ñ¼öÀÌ½Ä |
|---|---|---|---|
| ¼³¸í | ȯÀÚÀÇ º´µç °ñ¼ö ´ë½Å °Ç°ÇÑ °ñ¼ö¼¼Æ÷¸¦ À̽ÄÇϴ óġ-¾ÏÄ¡·á¿¡ ¹æ»ç¼±¿ä¹ýÀ̳ª ÈÇпä¹ýÀ» ½èÀ» °æ¿ì ±× ºÎÀÛ¿ëÀ¸·Î °ñ¼öÀÇ ±â´ÉÀÌ ±Øµµ·Î ³ªºüÁ³À» ¶§³ª ¶Ç´Â ¹éÇ÷º´ÀÇ °æ¿ì¿¡ ¸é¿ª¿ä¹ýÀ¸·Î ÀÌ¿ëµÈ´Ù. ¹æ¹ýÀº °Ç°ÇÑ °ñ¼ö¾×À» äÃëÇÏ¿© Àλê¿ÏÃæ¾×À» ¼¯Àº ¸µ°Å¾×¿¡ ºÎÀ¯½ÃÄÑ ¿©°úÇÑ ´ÙÀ½ Á¤¸Æ¿¡ ÁÖ»çÇÑ´Ù. ÁÖÀÔÇÑ °ñ¼ö°¡ ü³»¿¡ Âø»óÇÏ¿© ¹ø½ÄÇϱ⠽±°Ô ÇÒ ¸ñÀûÀ¸·Î ¹Ì¸® X¼±À» Á¶»çÇÏ¿© À̽Ĺ޴ ȯÀÚÀÇ Ç×ü±â´ÉÀ» ¾ïÁ¦ÇØ µÑ Çʿ䰡 ÀÖ´Ù. ÀÌ Á¶ÀÛÀº ±Þ¼º ¹æ»ç´ÉÁõÀ» ÀÏÀ¸Å°±â ¶§¹®¿¡ ¿©·¯ °¡Áö º¸È£Ä¡·á°¡ ÇÊ¿äÇÏ´Ù. ±×·¯³ª °ñ¼ö¸¦ À̽ÄÇÏ¸é ±Þ¼º ¹æ»ç´ÉÁõÀ» °¡º±°Ô ³Ñ±æ ¼ö ÀÖ´Ù°í ÇÏ¿© ¹Ý´ë·Î ¹æ»ç´ÉÀ» ´ë·®À¸·Î Á¶»ç¹ÞÀº »ç¶÷¿¡°Ô ±× Ä¡·á¹ýÀ¸·Î ÀÌ¿ëµÇ±âµµ ÇÑ´Ù. À̽Ŀ¡´Â ½º½º·ÎÀÇ °ñ¼ö¼¼Æ÷¸¦ ¹Ì¸® äÃëÇØ ³õ°í ÈÄ¿¡ Àڽſ¡°Ô ÁÖÀÔÇÏ´Â ÀÚ°¡À̽İú À϶õ¼º½ÖµÕÀÌÀÇ ÇÑÂÊ¿¡¼ °ñ¼ö¼¼Æ÷¸¦ ÁÖÀÔÇÏ´Â µ¿°èÀÌ½Ä ¹× Á¶Á÷ÀûÇÕÇ׿øÀÌ ÀÏÄ¡ÇÑ Å¸ÀÎÀÇ °ñ¼ö¼¼Æ÷¸¦ ÁÖÀÔÇÏ´Â µ¿Á¾À̽ÄÀÌ ÀÖ´Ù. ´ë»óº´À¸·Î ¹éÇ÷º´, Àç»ýºÒ·®ºóÇ÷, ¼±Ãµ¸é¿ª°áÇÌÁõ µîÀÌ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î °·ÂÇÑ ¸é¿ª¾ïÁ¦Á¦ÀÇ Åõ¿©°¡ ÇÊ¿äÇÏ´Ù. ºÎÀÛ¿ëÀ¸·Î¼´Â °ñ¼öÀÌ½Ä ÈÄ ÀÌ½ÄÆí´ë¼÷ÁÖº´, ±âȸ°¨¿° µîÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | zygomatic bone | ÇÑ±Û | ±¤´ë»À |
|---|---|---|---|
| ¼³¸í | ¾ó±¼º¼ºÎºÐÀÇ µ¹ÃâÀ» ¸¸µå´Â »ÀÀÌ¸ç ´«È®ÀÇ ¾Æ·¡ ¹Ù±ùÂÊ¿¡ À§Ä¡ÇÑ´Ù. ´ë·« ¸¶¸§¸ð²ÃÀ̸ç À§ÅλÀ, À̸¶»À ¹× °üÀÚ»ÀÀÇ ±¤´ë»Àµ¹±â¿¡ ³¢¾î ÀÖ´Ù. °üÀÚµ¹±â´Â µÚÂÊÀ¸·Î µ¹ÃâÇÏ¿© °üÀÚ»ÀÀÇ ±¤´ë»Àµ¹±â¿Í ¿¬°áÇÏ¸ç ±¤´ë»ÀȰÀ» ¸¸µç´Ù. ¸öü´Â 4¸éÀÌ ÀÖÀ¸¸ç ¾Æ·¡ÂÊ ³»¸éÀº À§ÅλÀÀÇ ±¤´ë»Àµ¹±â¿Í ºÀÇÕÇÑ´Ù. ¹Ù±ùÂʸ鿡´Â ±¤´ë»À¾ó±¼±¸¸ÛÀÌ °³±¸µÈ´Ù. À§ÂÊ ³»¸éÀº ´«È®¸éÀÌ¸ç ±¤´ë»À´«È®±¸¸ÛÀÌ °³±¸µÈ´Ù. ÈĸéÀº ¿·¸Ó¸®¸éÀÌ¸ç ±¤´ë»À ¿·¸Ó¸®±¸¸ÛÀÌ °³±¸µÈ´Ù. À̵é 3±¸¸ÛÀº ¸öü¸¦ °üÅëÇÏ´Â ±¤´ë»À°ü¿¡ ÀÇÇØ ¼·Î ¿¬¶ôµÇ¸ç ±¤´ë»À½Å°æÀÌ Áö³ª°£´Ù. |
||
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
|---|---|
| HD | Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ... |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
| AD | accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade... |
| BPTB | Bone-patellar tendon-bone |
|---|---|
| ABD | Adynamic Bone Disease |
| ADMR | Average daily metabolic rate |
| BMR | Basal Metabolic Rate |
| CMRGlu | Cerebral Metabolic Rate of Glucose |
| metabolic disease | Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (metabolism, inborn errors) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (12 Dec 1998) |
|---|---|
| basal metabolic rate | <biochemistry, biology> The metabolic rate as measured under basal conditions: 12 hours after eating, after a restful sleep, no exercise or activity preceding test, elimination of emotional excitement and occurring in a comfortable temperature. Acronym: BMR (15 Nov 1997) |
| brain diseases, metabolic | Metabolic disorders which lead to pathological changes and/or functional deviations of the brain. (12 Dec 1998) |
| rate, basal metabolic | A measure of the rate of metabolism. For example, someone with an overly active thyroid will have an elevated basal metabolic rate. (12 Dec 1998) |
| metabolic | 1. <biology> Of or pertaining to metamorphosis; pertaining to, or involving, change. 2. <physiology> Of or pertaining to metabolism; as, metabolic activity; metabolic force. Source: Websters Dictionary (01 Mar 1998) |
| metabolic acidosis | <biochemistry> A metabolic derangement of acid-base balance where the blood pH is abnormally low. Causes include haemorrhagic shock, cardiogenic shock, severe dehydration, sepsis, toxic ingestion (for example isopropyl alcohol, methanol), alcoholic ketoacidosis, lactic acidosis, renal failure and diabetic ketoacidosis. Respiratory acidosis will occur if the lungs are not ventilating properly. (27 Jun 1999) |
| metabolic alkalosis | <biochemistry> A metabolic derangement where the pH of the blood is abnormally high (basic). This condition may result from hyperventilation, the use of a particular drug, excessive vomiting or dehydration (contraction alkalosis). (27 Jun 1999) |
| metabolic burst | <biochemistry> Response of phagocytes to particles (particularly if opsonise d) and to agonists such as formyl peptides and phorbol esters, an enhanced uptake of oxygen leads to the production, by an NADH dependent system, of hydrogen peroxide, superoxide anions and hydroxyl radicals, all of which play a part in bactericidal activity. Defects in the metabolic burst, as in chronic granulomatous disease, predispose to infection particularly with catalase positive bacteria and are usually fatal in childhood. (27 Jun 1999) |
| metabolic calculus | A stone, usually a renal stone, caused by a metabolic abnormality resulting in increased excretion of a substance of low solubility in urine, such as urate or cystine. (05 Mar 2000) |
| metabolic clearance rate | Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. (12 Dec 1998) |
| metabolic coma | Coma resulting from diffuse failure of neuronal metabolism, caused by such abnormalities as intrinsic disorders of neuron or glial cell metabolism, or extracerebral disorders that produce intoxication or electrolyte imbalances. (05 Mar 2000) |
| metabolic cooperation | <cell biology, molecular biology> Transfer between tissue cells in contact of low molecular weight metabolites such as nucleotides and amino acids. Transfer is via channels constituted by the connexons of gap junctions and does not involve exchange with the extracellular medium. First observed in cultures of animal cells in which radio labelled purines were transferred from wild type cells to mutants unable to utilise exogenous purines. (27 Jun 1999) |
| metabolic coupling | <cell biology, molecular biology> Transfer between tissue cells in contact of low molecular weight metabolites such as nucleotides and amino acids. Transfer is via channels constituted by the connexons of gap junctions and does not involve exchange with the extracellular medium. First observed in cultures of animal cells in which radio labelled purines were transferred from wild type cells to mutants unable to utilise exogenous purines. (27 Jun 1999) |
| metabolic craniopathy | <syndrome> Hyperostosis frontalis interna in elderly women, with obesity and neuropsychiatric disorders of uncertain cause; at least sometimes familial. Synonym: metabolic craniopathy, Stewart-Morel syndrome. (05 Mar 2000) |
| metabolic detoxication, drug | Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|